INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 778.83 Million by 2030 | 13.61% | North America |
| by Product | by Technology | by Application |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
miRNA Sequencing and Assay Market Overview
The miRNA sequencing and assay market is expected to grow at 13.61% CAGR from 2023 To 2030. It is expected to reach above USD 778.83 Million by 2030 from USD 318.80 Million in 2023.
It is projected that the market would rise due to the expansion of technologically superior sequence analysis platforms. The discovery of previously uncharacterized miRNAs is made possible by miRNA sequence analysis, which also aids in the assessment of miRNA isoforms, the study of illness correlations, and the analysis of tissue-specific expression patterns. Since next-generation sequencing offers a better signal-to-noise ratio and facilitates efficient sequencing, it is typically favoured over microarrays for miRNA sequence analysis. In addition, small RNAs like siRNA, piRNA, and miRNA play a part in the differentiation and growth of cells as well as in the RNA-mediated epigenetic control of cellular processes like gene expression and death. Finding new miRNAs and other small RNAs is made simpler by short RNA sequence analysis, as is determining whether these nucleic acids are expressed differently in other samples. The approach is useful for the analysis of miRNAs without prior knowledge of their secondary structure or sequence, as well as for the single-base resolution identification of variations like isomiRs.
Furthermore, significant investments by important market companies have been prompted by the expanding usage of sequencing analytic techniques. As a result, the market has seen a rapid expansion of a sizable product line. The majority of these items are improvements over biotechnology goods that are already on the market. Competition may now launch and develop items more quickly than new entrants as a result.
The COVID-19 pandemic has had a substantial influence on the healthcare sector, increasing the need for specialized diagnostic equipment and personalized treatment. The pandemic has brought attention to the necessity for precise and quick diagnostic procedures that can locate the virus and monitor its progress. As a result, medical professionals have made significant investments in cutting-edge diagnostic techniques, such as molecular diagnostic procedures like PCR and fast antigen tests.
The pandemic has also brought attention to the value of personalized medicine, which entails modifying medical procedures and treatments for specific patients in light of their genetic makeup and other distinguishing traits. In the treatment of complex diseases like cancer, where different people may respond differently to the same medication, personalized medicine is becoming more and more crucial.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2030 |
| Base year | 2022 |
| Estimated year | 2023 |
| Forecasted year | 2023-2030 |
| Historical period | 2019-2021 |
| Unit | Value (USD Million) |
| Segmentation | By Product, By Technology, By Application, By End-user, By Region |
| By Product
 |
|
| By Technology |
|
| By Application |
|
| By End-user |
|
| By Region |
|
MiRNA sequencing and assay Market Segment Analysis
The miRNA sequencing and assay market is segmented based on product, product, application, end-user, and region.
Based on the product, the miRNA sequencing and assay market segmentation has been divided into library preparation and sequencing consumables. The library preparation is expected to dominate the product segmentation. In the miRNA sequencing and assay industry, library preparation is a crucial stage and is regarded as the leading product category. RNA samples are transformed into a sequencing library as part of the library preparation procedure so that they may be sequenced on an NGS platform. RNA isolation, enrichment, fragmentation, adapter ligation, and PCR amplification are all steps in the lengthy process of preparing libraries. To provide precise and repeatable results, this method needs top-notch reagents and tools. The market for miRNA sequencing and assays is expanding quickly, propelled by rising interest in personalized medicine and the discovery of novel disease biomarkers.
The miRNA sequencing and assay market has been segmented into sequencing by synthesis, nanopore sequencing, ion semiconductor sequencing, and sequencing by oligonucleotide ligation and detection (SOLiD). The sequencing by synthesis segment is expected to dominate the technology category in the projected period. With the help of the high-throughput sequencing method known as SBS, millions of DNA or RNA molecules can be simultaneously sequenced in a single run. SBS involves first attaching a single-stranded DNA or RNA template to a stable support, like a glass slide or a microfluidic chip. Then, fluorescently labeled nucleotides are inserted one at a time, and a camera or another imaging equipment records each incorporation event.
The miRNA sequencing and assay market is segmented into categories based on application, cancer, polyglutamine diseases, and schizophrenia. The miRNA sequencing and assay market’s leading application category at the moment is cancer. Due to miRNAs’ function in regulating gene expression and their involvement in the onset and development of cancer, miRNA sequencing and assay technology has become a crucial tool in cancer research and diagnostics. Small, non-coding RNA molecules known as miRNAs are essential for controlling the expression of genes. The onset and spread of numerous cancers, including breast, lung, prostate, and colon cancer, have been associated to dysregulated miRNA expression.
The miRNA sequencing and assay market is segmented into research institutes, academics, CRO (contract research organizations). Â The end-user sector for miRNA sequencing and assays is currently dominated by research institutes. Research institutes are crucial in advancing our understanding of miRNA function and their involvement in a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. miRNA sequencing and assay technology have become indispensable tools in molecular biology research. MiRNA sequencing and assay technology is used by research institutions for a variety of purposes, including the discovery of biomarkers, the diagnosis of diseases, the creation of new drugs, and fundamental studies.
MiRNA sequencing and assay Market Players
Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN N.V., PerkinElmer, Inc., Abcam plc, New England Biolabs, Takara Bio Inc., Lexogen GmbH, Norgen Biotek Corp., Maravai LifeSciences, HTG Molecular Diagnostics, Inc., Meridian Bioscience, Inc., System Biosciences, LLC, TriLink Biotechnologies Inc, Oxford Nanopore Technologies, Rosetta Genomics Ltd. are the major miRNA sequencing and assay market players.
Industry Developments:
14 March, 2023: Illumina Inc., announced its first product based on its novel Illumina Complete Long Read Technology now available to order.
03 January, 2023: Thermo Fisher Scientific announced the completion of acquisition of The Binding Site Group, a global leader in specialty diagnostics.
Who Should Buy? Or Key stakeholders
- Biotechnology and Pharmaceutical Companies
- Clinical Research Organizations (CROs)
- Healthcare Providers
- Patient Advocacy Groups
- Government & Regional Agencies
- Academic Research Institute
- Investors
- Regulatory Authorities
MiRNA sequencing and assay Market Regional Analysis
The MiRNA sequencing and assay market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina, and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
The miRNA sequencing and assay market was dominated by North America in 2021. The region is distinguished by the presence of several biotechnology and pharmaceutical firms, a developed healthcare infrastructure, and substantial amounts of public financing for R&D operations. MiRNA sequencing and assay technologies have been adopted more frequently in research and clinical settings as a result of the region’s rising desire for sophisticated diagnostic tools and personalised medicine. Asia Pacific is anticipated to have the miRNA sequencing and assay market’s fastest growth in 2021. The region’s healthcare industry is expanding quickly, propelled by factors like rising government financing for R&D initiatives, rising demand for cutting-edge diagnostic equipment and personalised treatment, and a sizable and ageing population.
Additionally, there is a growing need for novel and efficient diagnostic and treatment approaches in the area due to the rising frequency of chronic diseases like cancer, cardiovascular disease, and diabetes. The markets for miRNA sequencing and assay in Asia Pacific’s top three countries—China, Japan, and India—are anticipated to increase rapidly over the next few years. The presence of a sizable and fast expanding biotechnology sector, rising investments in healthcare infrastructure, and a growing emphasis on precision medicine and personalised healthcare have made China in particular a significant market for miRNA sequencing and testing. The miRNA sequencing and assay market is anticipated to experience substantial growth and innovation in the Asia Pacific region over the next several years. Another sizable market for miRNA sequencing and assay is Europe, which is supported by the region’s strong academic and research institutions as well as growing investments in personalised and precision medicine.
Key Market Segments: MiRNA sequencing and assay Market
miRNA sequencing and assay Market by Product, 2020-2030, (USD Million)
- Library Preparation
- Sequencing Consumables
miRNA sequencing and assay Market by Technology, 2020-2030, (USD Million)
- Sequencing By Synthesis
- Nanopore Sequencing
- Ion Semiconductor Sequencing
- Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
miRNA sequencing and assay Market by Application, 2020-2030, (USD Million)
- Cancer
- Polyglutamine Diseases
- Autoimmune Diseases
- Schizophrenia
miRNA sequencing and assay Market by End User, 2020-2030, (USD Million)
- Research Institute
- Academic
- CRO (Contract Research Organizations)
miRNA sequencing and assay Market by Region, 2020-2030, (USD Million)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new Product
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the miRNA sequencing and assay market over the next 7 years?
- Who are the major players in the miRNA sequencing and assay market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the miRNA sequencing and assay market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of academic policies and regulations on the miRNA sequencing and assay market?
- What is the current and forecasted size and growth rate of the global miRNA sequencing and assay market?
- What are the key drivers of growth in the miRNA sequencing and assay market?
- What are the distribution channels and supply chain dynamics in the miRNA sequencing and assay market?
- What are the technological advancements and innovations in the miRNA sequencing and assay market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the miRNA sequencing and assay market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the miRNA sequencing and assay market?
- What are the product offerings and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON MIRNA SEQUENCING AND ASSAY MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- END-USER VALUE CHAIN ANALYSIS
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET OUTLOOK
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION), 2020-2030
- LIBRARY PREPARATION
- SEQUENCING CONSUMABLES
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION), 2020-2030
- SEQUENCING BY SYNTHESIS
- NANOPORE SEQUENCING
- ION SEMICONDUCTOR SEQUENCING
- SEQUENCING BY OLIGONUCLEOTIDE AND LIGATION AND DETECTION (SOLID)
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION), 2020-2030
- CANCER
- POLYGLUTAMINE DISEASES
- AUTOIMMUNE DISEASES
- SCHIZOPHRENIA
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION), 2020-2030
- RESEARCH INSTITUTE
- ACADEMIA
- CRO (CONTRACT RESEARCH ORGANIZATIONS)
- GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY REGION (USD MILLION), 2020-2030
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- THERMO FISHER SCIENTIFIC, INC.
- ILLUMINA, INC.
- QIAGEN N.V.
- PERKINELMER, INC.
- ABCAM PLC
- NEW ENGLAND BIOLABS
- TAKARA BIO INC.
- LEXOGEN GMBH
- NORGEN BIOTEK CORP.
- MARAVAI LIFESCIENCES
- HTG MOLECULAR DIAGNOSTICS, INC.
- MERIDIAN BIOSCIENCE, INC.
- SYSTEM BIOSCIENCES, LLC
- TRILINK BIOTECHNOLOGIES INC
- OXFORD NANOPORE TECHNOLOGIES
- ROSETTA GENOMICS LTD. *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 2 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 3 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 4 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 5 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY REGION (USD MILLION) 2020-2030
TABLE 6 NORTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 7 NORTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 8 NORTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 9 NORTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 10 NORTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 11 US MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 12 US MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 13 US MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 14 US MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 15 CANADA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 16 CANADA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 17 CANADA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 18 CANADA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 19 MEXICO MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 20 MEXICO MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 21 MEXICO MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 22 MEXICO MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 23 SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 24 SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 25 SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 26 SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 27 SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 28 BRAZIL MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 29 BRAZIL MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 30 BRAZIL MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 31 BRAZIL MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 32 ARGENTINA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 33 ARGENTINA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 34 ARGENTINA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 35 ARGENTINA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 36 COLOMBIA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 37 COLOMBIA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 38 COLOMBIA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 39 COLOMBIA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 40 REST OF SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 41 REST OF SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 42 REST OF SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 43 REST OF SOUTH AMERICA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 44 ASIA-PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 45 ASIA-PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 46 ASIA-PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 47 ASIA-PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 48 ASIA-PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 49 INDIA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 50 INDIA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 51 INDIA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 52 INDIA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 53 CHINA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 54 CHINA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 55 CHINA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 56 CHINA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 57 JAPAN MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 58 JAPAN MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 59 JAPAN MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 60 JAPAN MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 61 SOUTH KOREA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 62 SOUTH KOREA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 63 SOUTH KOREA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 64 SOUTH KOREA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 65 AUSTRALIA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 66 AUSTRALIA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 67 AUSTRALIA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 68 AUSTRALIA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 69 SOUTH-EAST ASIA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 70 SOUTH-EAST ASIA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 71 SOUTH-EAST ASIA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 72 SOUTH-EAST ASIA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 73 REST OF ASIA PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 74 REST OF ASIA PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 75 REST OF ASIA PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 76 REST OF ASIA PACIFIC MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 77 EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 78 EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 79 EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 80 EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 81 EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 82 GERMANY MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 83 GERMANY MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 84 GERMANY MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 85 GERMANY MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 86 UK MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 87 UK MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 88 UK MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 89 UK MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 90 FRANCE MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 91 FRANCE MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 92 FRANCE MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 93 FRANCE MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 94 ITALY MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 95 ITALY MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 96 ITALY MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 97 ITALY MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 98 SPAIN MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 99 SPAIN MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 100 SPAIN MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 101 SPAIN MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 102 RUSSIA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 103 RUSSIA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 104 RUSSIA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 105 RUSSIA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 106 REST OF EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 107 REST OF EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 108 REST OF EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 109 REST OF EUROPE MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 110 MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 111 MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 112 MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 113 MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 114 MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 115 UAE MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 116 UAE MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 117 UAE MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 118 UAE MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 119 SAUDI ARABIA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 120 SAUDI ARABIA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 121 SAUDI ARABIA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 122 SAUDI ARABIA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 123 SOUTH AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 124 SOUTH AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 125 SOUTH AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 126 SOUTH AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
TABLE 127 REST OF MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT (USD MILLION) 2020-2030
TABLE 128 REST OF MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY (USD MILLION) 2020-2030
TABLE 129 REST OF MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION (USD MILLION) 2020-2030
TABLE 130 REST OF MIDDLE EAST AND AFRICA MIRNA SEQUENCING AND ASSAY MARKET BY END USER (USD MILLION) 2020-2030
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 RESEARCH FLOW
FIGURE 5 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT, USD MILLION, 2020-2030
FIGURE 6 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY, USD MILLION, 2020-2030
FIGURE 7 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION, USD MILLION, 2020-2030
FIGURE 8 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY END USER, USD MILLION, 2020-2030
FIGURE 9 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY REGION, USD MILLION, 2020-2030
FIGURE 10 PORTER’S FIVE FORCES MODEL
FIGURE 11 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY PRODUCT, USD MILLION, 2022
FIGURE 12 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY TECHNOLOGY, USD MILLION, 2022
FIGURE 13 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY APPLICATION, USD MILLION, 2022
FIGURE 14 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY END USER, USD MILLION, 2022
FIGURE 15 GLOBAL MIRNA SEQUENCING AND ASSAY MARKET BY REGION, USD MILLION, 2022
FIGURE 16 MARKET SHARE ANALYSIS
FIGURE 17 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 18 ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 19 QIAGEN N.V.: COMPANY SNAPSHOT
FIGURE 20 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 21 ABCAM PLC: COMPANY SNAPSHOT
FIGURE 22 NEW ENGLAND BIOLABS: COMPANY SNAPSHOT
FIGURE 23 TAKARA BIO INC.: COMPANY SNAPSHOT
FIGURE 24 LEXOGEN GMBH: COMPANY SNAPSHOT
FIGURE 25 NORGEN BIOTEK CORP.: COMPANY SNAPSHOT
FIGURE 26 MARAVAI LIFESCIENCES: COMPANY SNAPSHOT
FIGURE 27 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT
FIGURE 28 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT
FIGURE 29 SYSTEM BIOSCIENCES, LLC: COMPANY SNAPSHOT
FIGURE 30 TRILINK BIOTECHNOLOGIES INC: COMPANY SNAPSHOT
FIGURE 31 OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 32 ROSETTA GENOMICS LTD.: COMPANY SNAPSHOT
FAQ
The miRNA sequencing and assay market is expected to grow at 13.61% CAGR from 2023 To 2030. It is expected to reach above USD 778.83 Million by 2030 from USD 318.80 Million in 2023.
The driving factors for the market growth include the expansion of technologically advanced sequence analysis, the introduction of new technology and the launch of various techniques to assess the miRNA sequence.
The region’s largest share is in North America. Product that is manufactured in nations like US and Canada that perform similarly and are inexpensively accessible to the general public have led to the increasing appeal.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.